Abbott Vascular    
Home | Topics | Clinical Trials | Library | Abstracts | Grand Rounds | Meetings | Login  
           

Log In
 
 

Forgot Your Password?
 


Not a member? Click here!

CRT 2009
Preliminary Program
March 4 - 6, 2009


CRT 2009 Meeting Information
Call for Abstracts
Register for CRT 2009
Omni Shoreham Hotel, Washington, DC

click below to open:
CRT 2009 Preliminary Program

Preliminary Program (PDF)


ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions
Cardiac CT & MRI Imaging
Complex Coronary Interventions
Chronic Total Occlusion
Drug-Eluting Stents
Emerging Devices & Innovative Therapies
Nurse & Tech Corner
Peripheral Interventions
Vulnerable Plaque
Workshop with the FDA


Poll Archives


Oscar C. Marroquin, MD Off-label BMS versus DES
Oscar C. Marroquin, MD


8/25/2008
Sodium Bicarbonate vs Saline for the Prevention of Contrast-induced Nephropathy (CIN) in PTS with Renal Dysfunction Undergoing Coronary Angiography or Intervention
Mauro Maioli, Anna Toso, Mario Leoncini, Michela Gallopin, Delio Tedeschi, Carlo Micheletti and Francesco Bellandi

8/21/2008
CASPAR (Coronary Artery Spasm In Patients With Acute Coronary Syndrome)
Peter Ong, MD

8/15/2008
Health Status and Economic Outcomes in COURAGE
William S. Weintraub, MD

8/14/2008
SYNTAX (SYNergy between PCI with TAXUS and Cardiac Surgery)
SYNTAX

8/13/2008
Results From The EVENT Registry
Allen Jeremias, et al

8/13/2008
Safety of Coronary Angio and PCI in Patients on Oral Anticoagulation
Juhani Airaksinen, MD

8/11/2008
SBE Prophylaxis: 10 Points to Remember
Washington Hospital Center Cath Conference


8/21/2008
Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts
T Okabe, J Lindsay, AN Buch, et al.

8/21/2008
Impact of Mild or Moderate Renal Insufficiency on the Intravascular Ultrasonic Analysis of Chronic Vascular Response to Paclitaxel-Eluting and Bare-Metal Stents (from the TAXUS IV, V, and VI Trials)
J Aoki, GS Mintz, NJ Weissman, et al.

8/21/2008
Effect of Prolonged Thienopyridine Use After Drug-Eluting Stent Implantation (from the TAXUS Landmark Trials Data)
GW Stone, SG Ellis, A Colombo, et al.

8/21/2008
Impact of Optimal Medical Therapy and Revascularization on Outcome of Patients With Chronic Kidney Disease and on Dialysis Who Presented With Acute Coronary Syndrome
L Bonello, A De Labriolle, P Roy, et al.

8/15/2008
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention
A Kastrati, F-J Neumann, J Mehilli, et al.

8/15/2008
Effect of PCI on Quality of Life in Patients with Stable Coronary Disease
WS Weintraub, JA Spertus, P Kolm, et al.



About/Contact Us
CRT 2009 Call for Abstracts
CRT 2009 Meeting Information
SYNTAX (SYNergy between PCI with TAXUS and Cardiac Surgery)
CASPAR (Coronary Artery Spasm In Patients With Acute Coronary Syndrome)


CRT 2009: March 4-6, 2009, Washington, DC

CRT.VIVA ENDOVASCULAR INTENSIVE

Preliminary Agendas:
March 4, 2009: Neurovascular
March 5, 2009: Peripheral Arterial Disease
March 6, 2009: Aortic / Visceral / Venous
click on a title above to view the preliminary agenda


Dominick J. Angiolillo, MD, PhD Antiplatelet Resistance: What Does it Mean and What Should/Can we Do About it?
Dominick J. Angiolillo, MD, PhD
Eric R. Bates, MD Time to Treatment (and Transport) Issues: Selection of Reperfusion Modality, and Primary Angioplasty with No On-Site Surgery
Eric R. Bates, MD
Timothy D. Henry, MD Approaches to Shortening Door-to-Balloon Time: The Minneapolis Ambulance Triage Program
Timothy D. Henry, MD



8/27/2008
Colorado University and Boulder Biotech Company Team Up To Study Pythons For Clues To Heart Disease

8/27/2008
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008

8/27/2008
Circulation: Cardiovascular Genetics Debuts in October

8/19/2008
St. Jude Medical Announces CE Mark Approval and FDA Clearance for New Family of HIFU Surgical Ablation Products

8/19/2008
Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR®

8/18/2008
Atritech Files for Pre-market Approval Application for its WATCHMAN® LAA Closure Technology

8/12/2008
MIV Announces Excellent Safety and Efficacy of VESTAsynctm Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up

Save the Date for CRT 2009!

CRM JOURNAL

CRTonline Sponsors

Best Medical International

Cardiovascular Links

Click here for More Meetings & Events


Copyright © 2008, CRTONLINE - About / Contact Us. All rights reserved.Privacy Policy
Powered by Multiweb